Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer.
about
Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@en
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@nl
type
label
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@en
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@nl
prefLabel
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@en
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@nl
P2093
P2860
P356
P1476
Subsequent anti-VEGF therapy a ...... metastatic colorectal cancer.
@en
P2093
Tianzhu Qiu
Wensen Chen
Xiaofeng Chen
Yanhong Gu
P2860
P304
P356
10.2147/OTT.S149110
P407
P577
2018-01-22T00:00:00Z